RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Extended Apixaban Failed to Reduce VTE Risk in Medically Ill Patients
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 15
SP 12
OP 13
DO 10.1177/155989771115006
UL http://mdc.sagepub.com/content/11/15/12.2.abstract
AB An extended course of thromboprophylaxis with apixaban did not reduce the risk of venous thromboembolism (VTE, which consists of pulmonary embolism and deep venous thrombosis) and VTE-related death in medically ill patients compared with a shorter course of enoxaparin, according to findings from the Apixaban Dosing to Optimize Protection from Thrombosis trial [ADOPT; NCT00457002].